RWJ-676070

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRWJ-676070
Drug Alias NameRWJ-676070JNJ-17158063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor antagonistsVasopressin V2 receptor antagonists
TargetsVasopressin V2 receptorVasopressin V1a receptor
Therapy Area/IndicationsHyponatremiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsHyponatremiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A